Finance

Lists
KRK:WSE
Krka dd Novo Mesto
1 132,00 PLN
+0,35%
(+4,00) 1D
16 ოქტ, 17:00:00 GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for KRK...
Open
1 128,00 PLN
High
1 132,00 PLN
Low
1 120,00 PLN
Mkt. cap
8,43 მლრდ.
Avg. vol.
50,00
Volume
19,00
52-wk high
1 200,00 PLN
52-wk low
810,00 PLN
Shares outstanding
32,79 მლნ.
No. of employees
13 ათ.
Open
1 128,00 PLN
High
1 132,00 PLN
Low
1 120,00 PLN
Mkt. cap
8,43 მლრდ.
Avg. vol.
50,00
Volume
19,00
52-wk high
1 200,00 PLN
52-wk low
810,00 PLN
Shares outstanding
32,79 მლნ.
No. of employees
13 ათ.
News stories
From web sources and news partners
Profile
Krka, d. d., Novo mesto is an international generic pharmaceutical company with headquarters in Novo Mesto, Slovenia. In 2023, Krka Group's total sales amounted to 1.806 billion euros. The net profit of the Krka Group totalled €313.7 million. Krka sells products to more than 70 countries. In Slovenia the company has production sites in Ločna and Bršljin, Krško, Šentjernej and Ljutomer; several departments are spread across various parts of Ljubljana as well. Krka also has production and distribution centers in Russia, Poland, Croatia, and Germany. At the end of 2023, Krka Group had 12,753 employees. Wikipedia
About Krka dd Novo Mesto
CEOჟოზე კოლარიჩი
Employees13,3 ათ.
Founded23 აპრ. 1954
Headquarters-
SectorPharmaceutical industry
Websitekrka.biz
Last report
23 ივლ. 2026
Fiscal period
Q2 2026
- / -
Revenue / Est. (EUR)
553,57 მლნ. / 548,10 მლნ.
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
485,49 მლნ.
507,00 მლნ.
565,77 მლნ.
553,57 მლნ.
Cost of goods sold
208,02 მლნ.
208,84 მლნ.
223,77 მლნ.
213,31 მლნ.
Cost of revenue
208,02 მლნ.
208,84 მლნ.
223,77 მლნ.
213,31 მლნ.
Research and development expenses
48,88 მლნ.
44,42 მლნ.
51,37 მლნ.
48,68 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
119,68 მლნ.
158,52 მლნ.
140,38 მლნ.
135,48 მლნ.
Operating expense
167,29 მლნ.
202,22 მლნ.
190,40 მლნ.
182,64 მლნ.
Total operating expenses
375,31 მლნ.
411,06 მლნ.
414,17 მლნ.
395,95 მლნ.
Operating income
110,18 მლნ.
95,94 მლნ.
151,60 მლნ.
157,62 მლნ.
Other non operating income
-2,55 მლნ.
-3,17 მლნ.
234,00 ათ.
114,00 ათ.
EBT including unusual items
96,04 მლნ.
100,49 მლნ.
148,27 მლნ.
171,68 მლნ.
EBT excluding unusual items
96,04 მლნ.
98,43 მლნ.
148,27 მლნ.
171,68 მლნ.
Income tax expense
19,06 მლნ.
20,47 მლნ.
27,32 მლნ.
32,46 მლნ.
Effective tax rate
19,85%
20,37%
18,43%
18,91%
Other operating expenses
-1,26 მლნ.
-721,00 ათ.
-1,35 მლნ.
-1,53 მლნ.
Net income
77,08 მლნ.
80,31 მლნ.
120,95 მლნ.
139,31 მლნ.
Net profit margin
15,88%
15,84%
21,38%
25,17%
Earnings per share
-
-
-
-
Interest and investment income
2,69 მლნ.
2,85 მლნ.
2,53 მლნ.
2,61 მლნ.
Interest expense
-193,00 ათ.
-6,53 მლნ.
-203,00 ათ.
-192,00 ათ.
Net interest expenses
2,49 მლნ.
-3,68 მლნ.
2,33 მლნ.
2,42 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
132,28 მლნ.
118,66 მლნ.
174,36 მლნ.
180,58 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები